Diržius, E.; Pakanavičiūtė, R.; Andriuškevičiūtė, D.; Leskauskas, D.; Bulatov, A.
Variations in Oppel–Kundt Illusion Strength Among Depressive and Schizophrenia Spectrum Disorder Groups: Impact of Benzodiazepine Use. Medicina 2025, 61, 835.
https://doi.org/10.3390/medicina61050835
AMA Style
Diržius E, Pakanavičiūtė R, Andriuškevičiūtė D, Leskauskas D, Bulatov A.
Variations in Oppel–Kundt Illusion Strength Among Depressive and Schizophrenia Spectrum Disorder Groups: Impact of Benzodiazepine Use. Medicina. 2025; 61(5):835.
https://doi.org/10.3390/medicina61050835
Chicago/Turabian Style
Diržius, Edgaras, Rasa Pakanavičiūtė, Deimantė Andriuškevičiūtė, Darius Leskauskas, and Aleksandr Bulatov.
2025. "Variations in Oppel–Kundt Illusion Strength Among Depressive and Schizophrenia Spectrum Disorder Groups: Impact of Benzodiazepine Use" Medicina 61, no. 5: 835.
https://doi.org/10.3390/medicina61050835
APA Style
Diržius, E., Pakanavičiūtė, R., Andriuškevičiūtė, D., Leskauskas, D., & Bulatov, A.
(2025). Variations in Oppel–Kundt Illusion Strength Among Depressive and Schizophrenia Spectrum Disorder Groups: Impact of Benzodiazepine Use. Medicina, 61(5), 835.
https://doi.org/10.3390/medicina61050835